Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS

  • Read more about INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS
Patent Cooperation Treaty
PCT/US2012/020830
Filed on 2012-01-10

Methods for Amplification and Detection of Prions

  • Read more about Methods for Amplification and Detection of Prions
Patent Cooperation Treaty
PCT/US2012/021561
Filed on 2012-01-17

Treatment of Inflammatory Diseases by Targeting the Adaptor Protein CIKS

  • Read more about Treatment of Inflammatory Diseases by Targeting the Adaptor Protein CIKS
Patent Cooperation Treaty
PCT/US2011/062945
Filed on 2011-12-01

Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus

  • Read more about Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus
Japan
2011-225056
Filed on 2003-01-09

METHODS FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND INFLAMMATION

  • Read more about METHODS FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND INFLAMMATION
US Patent 8,716,301
Filed on 2011-12-02

Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses

  • Read more about Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses
US Patent 8,568,739
Filed on 2011-11-23

Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses

  • Read more about Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses
European Patent
10781321.4
Filed on 2010-05-28

NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS

  • Read more about NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS
US Patent 8,221,759
Filed on 2011-09-30

Construction of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virusf

  • Read more about Construction of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virusf
Australia
2011250694
Filed on 2011-11-10

Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

  • Read more about Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines
Patent Cooperation Treaty
PCT/US2011/064944
Filed on 2011-12-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 345
  • Page 346
  • Page 347
  • Page 348
  • Page 349
  • Page 350
  • Page 351
  • Page 352
  • Page 353
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health